Company filings profile · CIK 0001326706

ENvue Medical, Inc. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for ENvue Medical, Inc. (FEED): 9 filings in the last 90 days vs 13 in the prior 90 (filing-velocity cooling ↓ · 0.69×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Oct 15, 2026. Source-linked, daily-refreshed.

Material 8-K events — ENvue Medical, Inc.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Oct 14, 2026Entry into a Material Agreement; Material Direct Financial Obligation; Amendments to Bylaws/Charter; Financial Statements and Exhibits↗
Aug 31, 2026Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits↗
Aug 14, 2026Item 5.07↗
Aug 12, 2026Entry into a Material Agreement; Financial Statements and Exhibits↗
Jul 14, 2026Departure/Election of Directors or Officers; Financial Statements and Exhibits↗
Jul 10, 2026Delisting / Listing-Rule Failure; Financial Statements and Exhibits↗
Feb 6, 2026Departure/Election of Directors or Officers; Financial Statements and Exhibits↗
Jan 30, 2026Entry into a Material Agreement; Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits↗
Dec 30, 2025Departure/Election of Directors or Officers; Financial Statements and Exhibits↗

Watch ENvue Medical, Inc. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
Jun 22, 20264↗
Apr 17, 20264↗
Feb 26, 20263↗
Feb 11, 20263↗
Feb 11, 20264↗
Feb 4, 20264↗
Feb 4, 20263↗
Jan 12, 20263↗
Dec 29, 20253↗
Dec 18, 20253↗
Dec 18, 20253↗

Recent filings

FiledFormDetail
Oct 14, 20268-K Entry into a Material Agreement; Material Direct Financial Obligation; Amendments to Bylaws/Charter; Financial Statements and Exhibits ↗
Sep 3, 2026EFFECT Item ; Item ; Item ↗
Aug 31, 20268-K Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits ↗
Aug 17, 202610-Q 10-Q ↗
Aug 14, 2026NT 10-Q NT 10-Q ↗
Aug 14, 20268-K Item 5.07 ↗
Aug 12, 20268-K Entry into a Material Agreement; Financial Statements and Exhibits ↗
Aug 10, 2026S-3 S-3 ↗
Jul 24, 2026DEF 14A DEF 14A ↗
Jul 14, 2026PRE 14A PRE 14A ↗
Jul 14, 20268-K Departure/Election of Directors or Officers; Financial Statements and Exhibits ↗
Jul 10, 20268-K Delisting / Listing-Rule Failure; Financial Statements and Exhibits ↗
Jun 22, 2026SCHEDULE 13D/A ↗
Jun 22, 20264 PRIMARY DOCUMENT ↗
May 28, 2026EFFECT Item ; Item ; Item ↗
May 28, 2026424B3 424B3 ↗
May 26, 2026CORRESP ↗
May 26, 2026UPLOAD ↗
May 18, 2026S-3 S-3 ↗
May 18, 202610-Q 10-Q ↗
May 15, 2026NT 10-Q NT 10-Q ↗
May 13, 2026144 ↗
Apr 17, 20264 PRIMARY DOCUMENT ↗
Apr 17, 2026SCHEDULE 13D/A ↗
Apr 15, 202610-K 10-K ↗
Mar 31, 2026NT 10-K NT 10-K ↗
Mar 6, 2026SCHEDULE 13G/A ↗
Feb 26, 20263 3 ↗
Feb 11, 20263 PRIMARY DOCUMENT ↗
Feb 11, 20264 PRIMARY DOCUMENT ↗
Feb 11, 2026SCHEDULE 13D ↗
Feb 6, 2026SCHEDULE 13G ↗
Feb 6, 20268-K Departure/Election of Directors or Officers; Financial Statements and Exhibits ↗
Feb 5, 20263/A PRIMARY DOCUMENT ↗
Feb 4, 20264 PRIMARY DOCUMENT ↗
Feb 4, 20263 PRIMARY DOCUMENT ↗
Jan 30, 20268-K Entry into a Material Agreement; Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits ↗
Jan 12, 20263 ↗
Dec 30, 20258-K Departure/Election of Directors or Officers; Financial Statements and Exhibits ↗
Dec 29, 20253 ↗